Phil Falkowitz's Clinical Trial Experience Is Featured in Journal Article
PMMNG member Phil Falkowitz started taking Revlimid (lenalidomide) way back in 2001, during the Phase 1 clinical trial of Revlimid. That trial went well for him (and for Revlimid).
Myeloma Crowd: First Risk-Adapted Therapy Trial for Newly Diagnosed Patients (the MASTER trial)
What: Audio (59:29) and transcript from webinar
When: Monday April 16, 2018
Where: Web
More Info
LLS: Clinical Trials for Blood Cancers - How can participating in a clinical trial help me?
What: Webcast
When: Wednesday, April 18, 2018 Noon - 1:00 PM ET
Where: Web
More Info: http://www.lls.org/events/clinical-trials-for-blood-cancers-how-can-participating-in-a-clinical-trial-help-me
Patient Cafe: Multiple Myeloma – Participating in a Clinical Trial
What: Transcript and Video from webinar panel discussion
When: Thursday June 20, 2018
Where: Web
IMF: Clinical Trials in Myeloma 2018
What: Webinar
When: Thursday, November 1, 2018 7:00 PM ET
Where: Web
Slides & Webcast Video
November News Items
We've got a few news items to pass along: